What is Neolight?
Neolight LLC operates at the intersection of medical technology and neonatal care, providing a suite of sophisticated solutions designed to address critical health challenges in infants. The company's flagship offerings, such as the Skylife Neonatal Phototherapy System, represent a shift toward more efficient, empathy-driven clinical tools. Beyond phototherapy, Neolight integrates advanced brain monitoring and ocular screening capabilities into its product ecosystem. By focusing on the specific needs of hospitals and neonatal intensive care units, the firm has established itself as a vital partner for healthcare providers seeking to optimize jaundice treatment and neurological assessment protocols. Their holistic approach, which includes non-nutritive sucking aids and professional educational resources, positions them as a comprehensive provider in the pediatric medical device market.
How much funding has Neolight raised?
Neolight has raised a total of $7.8M across 3 funding rounds:
Angel/Seed
$600K
Debt
$150K
Unspecified
$7M
Angel/Seed (2016): $600K, investors not publicly disclosed
Debt (2020): $150K led by PPP
Unspecified (2020): $7M supported by Ben Roethlisberger, Honor Health Systems, Ashley Roethlisberger, and Dignity Health
Key Investors in Neolight
Dignity Health
A major non-profit healthcare system that operates a vast network of hospitals and care centers, focusing on integrated clinical services and community health.
Honor Health Systems
A healthcare organization dedicated to providing comprehensive medical services and improving patient outcomes through strategic clinical investments.
Ben Roethlisberger
A private investor participating in the funding round to support advancements in neonatal medical technology.
What's next for Neolight?
With the recent influx of capital, Neolight is well-positioned to accelerate its research and development pipeline, focusing on the next generation of neonatal monitoring and therapeutic devices. The company is expected to leverage this financial backing to scale its distribution networks and deepen its penetration into major hospital systems. As the firm transitions from its earlier development phases into a more mature enterprise-level operation, the strategic focus will likely shift toward regulatory expansion and the integration of data-driven analytics into their existing hardware platforms. This growth trajectory suggests a sustained effort to dominate the neonatal care niche through continuous innovation and strategic partnerships with major health systems.
See full Neolight company page
